Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Generic drug APIs and intermediates	1.99B	2.00B	2.35B	1.96B	2.49B
Generic drug APIs and intermediates Growth	-0.53%	-14.69%	19.66%	-21.20%	99.68%
CDMO APIs and Intermediates	365.80M	405.66M	263.08M	557.24M	85.38M
CDMO APIs and Intermediates Growth	-9.83%	54.20%	-52.79%	552.65%	-90.02%
Preparations	254.76M	105.03M	33.97M	3.97M	-
Preparations Growth	142.56%	209.20%	754.85%	-	-
other	16.13M	11.84M	19.62M	19.88M	9.78M
other Growth	36.26%	-39.66%	-1.29%	103.22%	48.27%
Total	2.63B	2.53B	2.67B	2.55B	2.59B
Total Growth	4.10%	-5.23%	4.78%	-1.64%	22.59%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Export	1.72B	1.82B	1.86B	1.85B	1.88B
Export Growth	-5.55%	-2.45%	0.71%	-1.35%	42.31%
China	914.11M	709.76M	803.49M	695.04M	712.13M
China Growth	28.79%	-11.66%	15.60%	-2.40%	-10.18%
Total	2.63B	2.53B	2.67B	2.55B	2.59B
Total Growth	4.10%	-5.23%	4.78%	-1.64%	22.59%

Source: S&P Global Market Intelligence.